Triple-Nucleoside Regimens versus Efavirenz-Containing Regimens for the Initial Treatment of HIV-1 Infection - Concepedia

Concepedia

Publication | Open Access

Triple-Nucleoside Regimens versus Efavirenz-Containing Regimens for the Initial Treatment of HIV-1 Infection

DOI Full Paper Access

526

Citations

33

References

2004

Year

Roy M. Gulick, Heather J. Ribaudo, Cecilia M. Shikuma, Stephanie Lustgarten, Kathleen Squires, William A. Meyer, Edward P. Acosta, Bruce R. Schackman, Christopher D. Pilcher, Robert L. Murphy,

New England Journal of Medicine

Abstract

In this trial of the initial treatment of HIV-1 infection, the triple-nucleoside combination of abacavir, zidovudine, and lamivudine was virologically inferior to a regimen containing efavirenz and two or three nucleosides.

References

	Year	Citations

Page 1